ArticleNature immunology2020
A new lymphoid-primed progenitor marked by Dach1 downregulation identified with single cell multi-omics.
Abstract read
In one paragraph
Article in Nature immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 37 citations in OpenAlex.
- T cell development from expanded hematopoietic progenitors reveals initiation control byScience immunology · 2026Article
- Conventional and Alternative B Lymphopoiesis: Multiple Roads to Immunity.Stem cell reviews and reports · 2026Review
- Leukemogenic Kras mutation reprograms multipotent progenitors to facilitate its spread through the hematopoietic system.The Journal of experimental medicine · 2025Article
- Resolving the spatial organization of fetal liver hematopoiesis by SeekSpace.Cell regeneration (London, England) · 2025Article
- miR-142 deficit in T cells during blast crisis promotes chronic myeloid leukemia immune escape.Nature communications · 2025Article
- Ever-evolving insights into the cellular and molecular drivers of lymphoid cell development.Experimental hematology · 2024Review
- In vivo CRISPR/Cas9-mediated screen reveals a critical function of TFDP1 and E2F4 transcription factors in hematopoiesis.Leukemia · 2024Article
- Clonal analysis of fetal hematopoietic stem/progenitor cells reveals how post-transplantation capabilities are distributed.Stem cell reports · 2024Article
- Dachshund Homolog 1: Unveiling Its Potential Role in Megakaryopoiesis andInternational journal of molecular sciences · 2024Article
- Advancements and applications of single-cell multi-omics techniques in cancer research: Unveiling heterogeneity and paving the way for precision therapeutics.Biochemistry and biophysics reports · 2024Review
- A time- and single-cell-resolved model of murine bone marrow hematopoiesis.Cell stem cell · 2024Article
- The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis.Frontiers in immunology · 2024Review
- Slow cycling and durable Flt3+ progenitors contribute to hematopoiesis under native conditions.The Journal of experimental medicine · 2024Article
- Multimodal cartography of human lymphopoiesis reveals B and T/NK/ILC lineages are subjected to differential regulation.iScience · 2023Article
- Stem cell decoupling underlies impaired lymphoid development during aging.Proceedings of the National Academy of Sciences of the United States of America · 2023Article
- Single-cell multi-omics and lineage tracing to dissect cell fate decision-making.Stem cell reports · 2023Review
- Temporal Gene Expression Profiles Reflect the Dynamics of Lymphoid Differentiation.International journal of molecular sciences · 2022Article
- Deciphering transcriptional and functional heterogeneity in hematopoiesis with single-cell genomics.Current opinion in hematology · 2021Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 4 institutions in 1 country.
Daniela Amann-Zalcenstein *Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0003-4928-1846
Luyi Tian *Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0003-3420-3685
Jaring Schreuder *Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0002-7579-0006
Sara Tomei *Immunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Dawn S LinImmunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0002-7872-6931
Kirsten A FairfaxDepartment of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
Jessica E BoldenDepartment of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
Mark D McKenzieDepartment of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
Andrew JarrattDepartment of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
Adrienne HiltonDepartment of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
Jacob T JacksonImmunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0002-6396-2739
Ladina Di RagoBlood Cells and Blood Cancer Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Matthew P McCormackAustralian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-1536-5611
Carolyn A de GraafDepartment of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
Olivia StonehouseFaculty of Medicine, Dentistry & Health Sciences, University of Melbourne, Parkville, Victoria, Australia.
Samir TaoudiEpigenetics and Development Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Warren S AlexanderDepartment of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
Stephen L NuttImmunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0002-0020-6637
Matthew E RitchieEpigenetics and Development Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0002-7383-0609
Ashley P NgDepartment of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0001-9690-0879
Shalin H NaikImmunology Division, The Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. naik.s@wehi.edu.au.ORCID http://orcid.org/0000-0003-0299-3301
The University of Melbourne · AUWalter and Eliza Hall Institute of Medical Research · AUAustralian Centre for HIV and Hepatitis Virology Research · AUUniversity of Tasmania · AU
Funding
No grant is acknowledged in the PubMed record.
Abstract
A classical view of blood cell development is that multipotent hematopoietic stem and progenitor cells (HSPCs) become lineage-restricted at defined stages. Lin
Indexed as
BiomarkersGenomicsSingle-Cell AnalysisAnimalsCells, CulturedComputational BiologyEye ProteinsGene Expression ProfilingHematopoiesisHigh-Throughput Nucleotide SequencingLymphoid Progenitor CellsMiceMice, KnockoutMice, TransgenicProteomicsBiomarkersDach1 protein, mouseEye Proteins
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.